期刊文献+

谷氨酰胺对兔梗阻性黄疸肠粘膜屏障的保护作用 被引量:2

Protective effect of glutamine on impaired intestine mucosal barrier in rabbits with obstructive jaundice
下载PDF
导出
摘要 目的观察谷氨酰胺对兔梗阻性黄疸肠粘膜屏障功能损害的保护作用。方法部分结扎胆总管制备梗阻性黄疸兔模型后,行静脉置管后注射丙氨酰谷氨酰胺1 mg.Kg-1(A组),假手术组(B组)和黄疸模型组(C组)给予生理氯化钠溶液。于术后24 h处死动物后检测静脉血内毒素水平和血清二胺氧化酶(d iam ineoxidase,DAO)变化,观察小肠粘膜上皮变化并进行组织病理评分。结果阻塞性黄疸组血清总胆红素较假手术组明显增高(P<0.05)。与C组比较,A组静脉血内毒素明显降低(P<0.05),血清二胺氧化酶明显降低(P<0.05),A组肠上皮粘膜病理学评分明显优于C组(P<0.05)。结论谷氨酰胺可保护梗阻性黄疸时小肠粘膜屏障功能,减少内毒素血症的发生,对改善预后有一定作用。 Objective:To investigate the protective effect of glutamine(Gln)on impaired intestine mucosalbarrier in rabbits with obstructive jaundice.Methods:After the obstructive jaundice was induced by ligation of cornmon bile duct,the rats were treated with alanyglutamine 1mg·Kg-1(Group A),Group C was given the same amout of normal saline.At 24h after the end of treatments,the endotoxin and diamineoxidase of plasma were measured,the mucosa was observed,and the biography rate was made.Results:The indices related to the DAO,endotoxin level and biography rate were higher in Group C than those in Group A(P0.05).Conclusion: The intestinal mucosal baeeier may be injuryed during the obstructive jaundice.The Gln has significant effect in protecting the mucosal barrier.
出处 《泰山医学院学报》 CAS 2010年第11期834-836,共3页 Journal of Taishan Medical College
关键词 谷氨酰胺 梗阻性黄疸 内毒素血症 二胺氧化酶 glutamine obstructive jaundice endotoxemia diamineoxidase
  • 相关文献

参考文献8

二级参考文献13

  • 1Jiin-Haur Chuang M.D.,Chie-Song Shieh M.D.,Nyuk-Kong Chang D.V.M.,Wei-Jen Chen M.D.,Jer-Nan Lin M.D.. Role of parenteral nutrition in preventing malnutrition and decreasing bacterial translocation to liver in obstructive jaundice[J] 1993,World Journal of Surgery(5):580~585
  • 2Dr. Gerald D. Iliffe MB, ChB, FRCP(C),David A. Owen MB, BCh, MRCPath, FRCP(C). An association between primary biliary cirrhosis and jejunal villous atrophy resembling celiac disease[J] 1979,Digestive Diseases and Sciences(10):802~806
  • 3Dr. R. J. A. Goris. Mediators of multiple organ failure[J] 1990,Intensive Care Medicine(3):S192~S196
  • 4Dr. P. McClelland,P. S. Williams,M. Yaqoob,S. M. Mostafa,J. M. Bone. Multiple organ failure—a role for plasma exchange?[J] 1990,Intensive Care Medicine(2):100~103
  • 5Toi M,Kondo S,Suzuki H,et al.Quantitative analysis of vascular endothelial growth factor in primary breast cancer[].Cancer.1996
  • 6Yakar S,Liu J L,Stannard B,et al.Normal growth and development in the absence of hepatic insulin-like growth factor I[].Proceedings of the National Academy of Sciences of the United States of America.1999
  • 7Volm M,Koomagi R,Mattern J,et al.Angiogenic growth factors and their receptors in non-small cell lung carcinomas and their relationships to drug response in vitro[].Anticancer Research.1997
  • 8Geran RI,Greenberg NH,Macdonald MM,et al.Protocols for screening chemical agents and natural products against animal tumors and other biological systems[].Cancer Chemotherapy Reports.1972
  • 9Liu JL,Grinberg A,Westphal H,et al.Insulin-like growth factor-I affects perinatal lethality and postnatal development in a gene dosage-dependent manner: manipulation using the Cre/loxP system in transgenic mice[].Journal of Molecular Endocrinology.1998
  • 10Dunger DB,Acerini CL.Does recombinant human insulin-like growth factor-1 have a role in the treatment of diabetes[].Diabetic Medicine.1997

共引文献13

同被引文献11

引证文献2

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部